Skip to main content

Platelet-Activating Factor: Mechanisms of Cellular Activation

  • Chapter

Abstract

Platelet-activating factor (PAF) is a phosphatidylcholine containing a long-chain alkyl ether at position 1 and an acetate ester at position 2 (Blank et al., 1979; Demopoulos et al., 1979; Polonsky et al., 1980):

Various cell types form and secrete this product when stimulated. PAF is found in the blood of animals undergoing experimentally induced toxic reactions such as anaphylaxis, serum sickness, and endotoxemia. It can mimic these reactions when injected intravenously into healthy animals. In particular, PAF infusion produces the activation of intravascular leukocytes and platelets, contraction of pulmonary airways, vascular instability, enhanced capillary permeability, and cardiac abnormalities. Deposited locally into tissues, PAF promotes edema and leukocyte accumulation. These results implicate PAF as a mediator of allergic and inflammatory reactions. However, even the most complex, systemic effects of PAF must result from fundamental interactions with target cells. Some understanding of these interactions has been obtained using in vitro studies on tissues containing one or only a few cell types.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Avdonin, P. V., Svitina-Ulitina, I. V., and Kulikov, V. I., 1985, Stimulation of high-affinity hormone-sensitive GTPase of human platelets by l-0-alkyl-2-0-acetyl-sn-glyceryl-3-phosphocholine (platelet activating factor), Biochem. Biophys. Res. Commun. 131:307–313.

    Article  PubMed  CAS  Google Scholar 

  • Beaubien, B. B., Tippins, J. R., and Morris, H. R., 1984, Platelet-activating factor stimulation of peptidoleukotriene release: Inhibition by vasoactive polypeptide, Biochem. Biophys. Res. Commun. 125:105–108.

    Article  PubMed  CAS  Google Scholar 

  • Berridge, M. J., and Irvine, R. F., 1984, Inositol trisphosphate, a novel second messenger in cellular signal transduction, Nature 312:317–321.

    Article  Google Scholar 

  • Blank, M. L., Snyder, F., Byers, L. W., Brooks, B., and Muirhead, E. E., 1979, Antihypertensive activity of an alkyl ether analog of phosphatidylcholine, Biochem. Biophys. Res. Commun. 90:1194–1200.

    Article  PubMed  CAS  Google Scholar 

  • Blank, M. L., Cress, E. A., Lee, T.-C., Malone, B., Surles, J. R., Piantadosi, C., Hajdu, J., and Snyder, F., 1982, Structural features of platelet activating factor (l-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses, Res. Commun. Chem. Pathol. Pharmacol. 38:3–20.

    PubMed  CAS  Google Scholar 

  • Camussi, G., Montrucchio, G., Antro, C., Bussolino, F., Tetta, C., and Emanuelli, G., 1983, Platelet-activating factor-mediated contraction of rabbit lung strips: Pharmacologic modulation, Immunopharmacology 6:87–96.

    Article  PubMed  CAS  Google Scholar 

  • Cazenave, J. P., Benveniste, J., and Mustard, J. F., 1979, Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs, Lab. Invest. 41:275–285.

    PubMed  CAS  Google Scholar 

  • Chesney, C. M., Pifer, D. D., Byers, L. W., and Muirhead, E. E., 1982, Effect of platelet-activating factor (PAF) on human platelets, Blood 59:582–585.

    PubMed  CAS  Google Scholar 

  • Chesney, C.M., Pifer, D. D., and Huch, K. M., 1983, Alpha-adrenergic antagonists inhibit binding of platelet-activating factor (PAF) to human gel-filtered platelets, J. Pharmacol. 14:21 (Suppl. 1).

    Google Scholar 

  • Chesney, C. M., Pifer, D. D., and Huch, K. M., 1985, Desensitization of human platelets by platelet activating factor, Biochem. Biophys. Res. Commun. 127:24–30.

    Article  PubMed  CAS  Google Scholar 

  • Chilton, F. H., O’Flaherty, J. T., Walsh, C. E., Thomas, M. J., Wykle, R. L., DeChatelet, L. R., and Waite, B. M., 1982, Platelet activating factor: Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by l-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine, J. Biol. Chem. 257:5402–5407.

    PubMed  CAS  Google Scholar 

  • Dahl, M. L., 1985, Aggregating and prostanoid-releasing effects of platelet-activating factor and leuko-trienes on human polymorphonuclear leukocytes and platelets, Int. Arch. Allergy Appl. Immunol. 76:145–150.

    Article  PubMed  CAS  Google Scholar 

  • Demopoulos, C. A., Pinckard, R. N., and Hanahan, D. J., 1979, Evidence for l-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators), J. Biol. Chem. 254:9355–9358.

    PubMed  CAS  Google Scholar 

  • Doebber, T. W., Wu, M. S., Robbins, J. C., Choy, B. M., Chang, M. N., and Shen, T. Y., 1985, Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonists kadsurenone, Biochem. Biophys. Res. Commun. 127:799–808.

    Article  PubMed  CAS  Google Scholar 

  • Ford-Hutchinson, A. W., 1983, Neutrophil aggregating properties of PAF-acether and leukotriene B4, Int. J. Immunopharmacol. 5:17–21.

    Article  PubMed  CAS  Google Scholar 

  • Gorman, R. R., Morton, D. R., Hopkins, N. K., and Lin, A. H., 1983, Acetyl glyceryl ether phos-phorylcholine stimulates leukotriene B4 synthesis and cyclic AMP accumulation in human polymorphonuclear leukocytes, Adv. Prostaglandin, Thromboxane, Leukotriene Res. 12:57–63.

    CAS  Google Scholar 

  • Hallam, T. J., Rink, T. J., and Sanchez, A., 1983, Elevation of cytoplasmic calcium concentration in human platelets by platelet-activating factor, Br. J. Pharmacol. 79:35IP.

    Google Scholar 

  • Hartung, H. P., 1983, Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages. Studies on PGE, TXB2 and O2 production, spreading, and the influence of calmodulin-inhibitor W-7, FEBS Lett. 160:209–212.

    Article  PubMed  CAS  Google Scholar 

  • Haslam, R. J., and Vanderwell, M., 1982, Inhibition of platelet adenylate cyclase by l-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor), J. Biol. Chem. 257:6879–6885.

    PubMed  CAS  Google Scholar 

  • Heymans, F., Borrel, M. C., Broquet, C., Lefort, J., and Godfroid, J. J., 1985, Structure-activity relationship in PAF-acether. 2. rac-l-0-octadecyl-2-0-acetyl-3-0-[(dimethyl amino)propyl]glyc-erol, J. Med. Chem. 28:1094–1096.

    Article  PubMed  CAS  Google Scholar 

  • Hwang, S. B., Lee, C. S. C., Cheah, M. J., and Shen, T. Y., 1983, Specific receptor sites for l-O-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) on rabbit platelet and guinea pig smooth muscle membranes, Biochemistry 22:4756–4763.

    Article  PubMed  CAS  Google Scholar 

  • Hwang, S. B., Lam, M. H., and Pong, S. S., 1985, Regulation of 3H-PAF binding to its receptors by ions and GTP and PAF-induced activation of GTPase in rabbit platelet membranes, October 15–18, 1985, New Horizons in Platelet Activating Factor Research, Mariner’s Inn, Palmetto Dunes Resort, Hilton Head Island, South Carolina.

    Google Scholar 

  • Ieyasu, H., Takai, Y., Kaibuchi, K., Sawamura, M., and Nishizuka, Y., 1982, A role of calcium-activated, phospholipid-dependent protein kinase in platelet-activating factor-induced serotonin release from rabbit platelets, Biochem. Biophys. Res. Commun. 108:1701–1708.

    Article  PubMed  CAS  Google Scholar 

  • Ingraham, L. M., Coates, T. D., Allen, J. M., Higgins, C. P., Baehner, R. L., and Boxer, L. A., 1982, Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor, Blood 59:1259–1266.

    PubMed  CAS  Google Scholar 

  • Irvine, R. F., 1982, How is the level of free arachidonic acid controlled in mammalian cells?, Biochem. J. 204:3–16.

    PubMed  CAS  Google Scholar 

  • Kawaguchi, H., and Yasuda, H., 1984, Platelet-activating factor stimulates phospholipase in quiescent Swiss mouse 3T3 fibroblast, FEBS Lett. 176:93–96.

    Article  PubMed  CAS  Google Scholar 

  • Kenzora, J. L., Perez, J. E., Bergmann, S. R., and Lange, L. G., 1984, Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs, J. Clin. Invest. 74:1193–1203.

    Article  PubMed  CAS  Google Scholar 

  • Khan, S. N., Lane, P. A., and Smith, A. D., 1985, Disaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins, Eur. J. Pharmacol. 107:189–198.

    Article  PubMed  CAS  Google Scholar 

  • Kornecki. E., Ehrlich, Y. H., and Lenox, R. H., 1984. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science 226:1454–1456.

    Article  PubMed  CAS  Google Scholar 

  • Lad, P. M., Olson. C. V., and Grewal. I. S., 1985a, Platelet activating factor and other mediators of inflammation act through a pertussis toxin sensitive GTP binding protein, October 15–18. New Horizons in Platelet Activating Factor Research, Mariner’s Inn, Palmetto Dunes Resort, Hilton Head Island, South Carolina.

    Google Scholar 

  • Lad. P. M., Olson. C. V., and Grewal. I. S., 1985b, Platelet-activating factor mediated effects on human neutrophil function are inhibited by pertussis toxin. Biochem. Biophys. Res. Commun. 129:632-638.

    Article  PubMed  CAS  Google Scholar 

  • Lanara, E., Vakirtzi-Lemonias, C., Kritikou, L., and Demopoulos, C. A., 1982, Response of mice and mouse platelets to acetyl glyceryl ether phosphorylcholine. Biochem. Biophys. Res. Commun. 109:1148–1156.

    Article  PubMed  CAS  Google Scholar 

  • Lapetina, E. G., and Siegel, F. L., 1982, Shape change induced in human platelets by platelet-activating factor, J. Biol. Chem. 258:7241–7244.

    Google Scholar 

  • Lee, T., Malone, B., Blank. M. L., and Snyder, F., 1981, l-alkyl-2-acetyl-sn-glycero-3-phos-phocholine (platelet-activating factor) stimulates calcium influx in rabbit platelets, Biochem. Biophys. Res. Commun. 102:1262-1268.

    Article  PubMed  CAS  Google Scholar 

  • Lee, T., Malone, B., and Snyder, F., 1983, Stimulation of calcium uptake by l-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in rabbit platelets: Possible involvement of the lipoxygenase pathway, Arch. Biochem. Biophys. 223:33-39.

    Article  PubMed  CAS  Google Scholar 

  • Lewis. A. J., Dervinis. A., and Chang, J., 1984, The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation, Agents Actions 15:636–642.

    Article  PubMed  CAS  Google Scholar 

  • Lewis, R. A., and Austen, K. F., 1984, The biologically active leukotrienes biosynthesis, metabolism, receptors, functions, and pharmacology, J. Clin. Invest. 73:889-897.

    Article  PubMed  CAS  Google Scholar 

  • Lin, A. H., Morton, D. R., and Gorman, R. R., 1982, Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes, J. Clin. Invest. 70:1058–1065.

    Article  PubMed  CAS  Google Scholar 

  • Marcus, A. J., Safier, L. B., Ullman, H. L., Wong, K. T. H., Broekman. M. J., Weksler, B. B., and Kaplan, K. L., 1981, Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro, Blood 58:1027–1031.

    PubMed  CAS  Google Scholar 

  • Maridonneau-Parini, I., Lagente, V., Lefort, J., Randon, J., Russo-Marie, F., and Vargaftig, B. B., 1985, Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig, Biochem. Biophys. Res. Commun. 131:42–49.

    Article  PubMed  CAS  Google Scholar 

  • Mauco, G., Chap, H., and Douste-Blazy, L., 1983, Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets, FEBS Lett. 153:361– 365.

    Article  PubMed  CAS  Google Scholar 

  • Mendlovic, F., Corvera, S., and Garcia-Sainz, J. A., 1984, Possible involvement of cyclooxy-genase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver, Biochem. Biophys. Res. Commun. 123:507–514.

    Article  PubMed  CAS  Google Scholar 

  • Mueller, H. W., O’Flaherty, J. T., and Wykle, R. L., 1983, Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils, J. Biol. Chem. 258:6213–6218.

    PubMed  CAS  Google Scholar 

  • Nishihira, J., and O’Flaherty, J. T. ,1985, Phorbol myristate acetate receptors in human polymorphonuclear neutrophils, J. Immunol. 135:3439–3447.

    PubMed  CAS  Google Scholar 

  • Nishihira, J., Ishibashi, T., Imai, Y., and Muramatsu, T., 1986, Purification and characterization of the specific binding protein for platelet activating factor (l-0-alkyl-2-acetyl-sn-glycero-3-phos-phocholine) from human platelets, Tohoku J. Exp. Med. (in press).

    Google Scholar 

  • Nishizuka, Y., 1984, The role of protein kinase C in cell surface signal transduction and tumour promotion, Nature 308:639–697.

    Article  Google Scholar 

  • O’Flaherty, J. T., 1982, Biology of disease. Lipid mediators of inflammation and allergy, Lab. Invest. 47:314–329.

    PubMed  Google Scholar 

  • O’Flaherty, J. T., 1985, Neutrophil degranulation: Evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE, J. Cell. Physiol. 122:229–239.

    Article  PubMed  Google Scholar 

  • O’Flaherty, J. T., Miller, C. H., Lewis, J. C., Wykle, R. L., Bass, D. A., McCall, C. E., Waite, M., and DeChatelet, L. R., 1981a, Neutrophil responses to platelet-activating factor, Inflammation 5:193–201.

    Article  PubMed  Google Scholar 

  • O’Flaherty, J. T., Swendsen, C. L., Lees, C. J., and McCall, C. E., 1981b, Role of extracellular calcium in neutrophil degranulation responses to l-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine, Am. J. Pathol. 105:107–113.

    PubMed  Google Scholar 

  • O’Flaherty, J. T., Lees, C. J., Miller, C. H., McCall, C. E., Lewis, J. C, Love, S. H., and Wykle, R. L., 1981c, Selective desensitization of neutrophils: Further studies with l-O-alkyl-srt-glycero-3-phosphocholine analogues, J. Immunol. 127:731–737.

    PubMed  Google Scholar 

  • O’Flaherty, J. T., Hammett, M. J., Shewmake, T. B., Wykle, R. L., Love, S. H., McCall, C. E., and Thomas, J. M., 198Id, Evidence for 5,12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation, Biochem. Biophys. Res. Commun. 103:552–558.

    Article  PubMed  Google Scholar 

  • O’Flaherty, J. T., Wykle, R. L., McCall, C. E., Shewmake, T. B., Lees, C. J., and Thomas, M., 198le, Desensitization of the human neutrophil degranulation response: Studies with 5,12-di-hydroxy-6,8,10,14-eicosatetraenoic acid, Biochem. Biophys. Res. Commun. 101:1290–1296.

    Article  PubMed  Google Scholar 

  • O’Flaherty, J. T., Salzer, W. L., Cousart, S., McCall, C. E., Piantadosi, C., Surles, J. R., Hammett, M. J., and Wykle, R. L., 1983, Platelet-activating factor and analogues: Comparative studies with human neutrophils and rabbit platelets, Res. Commun. Chem. Pathol. Pharmacol. 39:291–309.

    PubMed  Google Scholar 

  • O’Flaherty, J. T., Schmitt, J. D., Wykle, R. L., Redman, J. F., and McCall, C. E., 1985, Di-acylglycerols and Mezerein activate neutrophils by a phorbol myristate acetate-like mechanism, J. Cell. Phys. 125:192–199.

    Article  Google Scholar 

  • O’Flaherty, J., Kosfeld, S., and Nishihira, J., 1986, Binding and metabolism of leukotriene B4 by neutrophils and their subcellular organelles, J. Cell. Physiol. 126:359–370.

    Article  PubMed  Google Scholar 

  • Pfeilschifter, J., Kurtz, A., and Bauer, C., 1985, Inhibition of renin secretion by platelet activating factor (acetylglyceryl ether phosphorylcholine) in cultured rat renal juxtaglomerular cells, Biochem. Biophys. Res. Commun. 127:093–910.

    Article  Google Scholar 

  • Polonsky, J., Tence, M., Varenne, P., Das, B.C., Lunel, J., and Benveniste, J., 1980, Release of l-O-alkylglyceryl-3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: Chemical ionization mass spectrometry of phospholipids, Proc. Natl. Acad. Sci. USA 77:7019–7023.

    Article  PubMed  CAS  Google Scholar 

  • Samuelsson, B., 1982, The leukotrienes: An introduction, in Leukotrienes and Other Lipoxygenase Products (B. Samuelsson and R. Paoletti, eds.), Raven Press, New York.

    Google Scholar 

  • Satouchi, K., Pinckard, R. N., McManus, L. M., and Hanahan, D. J., 1981, Modification of the polar head group of acetyl glyceryl ether phosphorylcholine and subsequent effects upon platelet activation, J. Biol. Chem. 256:4425–4432.

    PubMed  CAS  Google Scholar 

  • Shaw, J. O., and Lyons, R. M., 1982, Requirements for different CaJ. T.+ pools in the activation of rabbit platelets, Biochim. Biophys. Acta 714:492–499.

    Article  PubMed  CAS  Google Scholar 

  • Shaw, J. O., Printz, M. P., Hirabayashi, K., and Henson, P. M., 1978, Role of prostaglandin synthesis in rabbit platelet activation induced by basophil-derived platelet-activating factor, J. Immunol. 121:1939–1945.

    PubMed  CAS  Google Scholar 

  • Shaw, J. O., Pinckard, R. N., Ferrigni, K. S., McManus, L. M., and Manahan, D. J., 1981, Activation of human neutrophils with l-0-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor), J. Immunol. 127:1250–1255.

    PubMed  CAS  Google Scholar 

  • Shen, T. Y., Hwang, S., Cheah, M. J., and Lee, C. C., 1983, Effects of nonsteroid antiinflammatory drugs (NSAIDS) on the specific binding of platelet activating factor (PAF) to membrane preparations of rabbit platelets, J. Pharmacol. 14:20.

    Google Scholar 

  • Shen, T. Y., Hwang, S., Chang, M. N., Doebber, T. W., Lam, M. T., Wu, M. S., Wang, X., Han, G. Q., and Li, R. Z., 1985, Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura) Specific inhibition of in vitro and in vivo platelet-activating factor-induced effects, Proc. Natl. Acad. Sci. USA 82:672–676.

    Article  PubMed  CAS  Google Scholar 

  • Shukla, D. D., and Hanahan, D. J., 1982, AGEPC (platelet activating factor) induced stimulation of rabbit platelets: Effects on phosphatidylinositol, di-and tri-phosphoinositides and phosphatidic acid metabolism, Biochem. Biophys. Res. Commun. 106:697–703.

    Article  PubMed  CAS  Google Scholar 

  • Shukla, S. D., Buxton, D. B., Olson. M. S., and Hanahan, D. J., 1983, Acetylglyceryl ether phos-phorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenosis, J. Biol. Chem. 258:10212–10214.

    PubMed  CAS  Google Scholar 

  • Smith, R. J., Bowman, B. J., and Iden, S. S., 1984, Stimulation of the human neutrophil superoxide anion-generating system with 1 -0-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorycholine, Biochem. Pharmacol. 33:973–978.

    Article  PubMed  CAS  Google Scholar 

  • Stimler, N. P., 1985, Parasympathetic stimulation as a mechanism for PAF-induced contractile responses in lung, October 15–18, New Horizons in Platelet Activating Factor Research, Mariner’s Inn, Palmetto Dunes Resort, Hilton Head Island, South Carolina.

    Google Scholar 

  • Stimler, N. P., and O’Flaherty. J. T., 1983, Spasmogenic properties of platelet-activating factor: Evidence for a direct mechanism in the contractile response of pulmonary tissues, Am. J. Pathol. 113:75–84.

    PubMed  CAS  Google Scholar 

  • Stimler, N. P., Bloor, C. M., Hugli, T. E., Wykle, R. L., McCall, C. E., and O’Flaherty, J. T., 1981, Anaphylactic actions of platelet-activating factor, Am. J. Pathol. 105:64–69.

    PubMed  CAS  Google Scholar 

  • Stimler, N. P., Gerard, C, and O’Flaherty, J. T., 1983, Contraction of human lung tissues by platelet-activating factor (AAGPC), INSERMS 23:195–204.

    CAS  Google Scholar 

  • Surles. J. R., Wykle, R. L., O’Flaherty, J. T., Salzer, W. L., Thomas, M. J., Snyder, P., and Piantadosi, C., 1984, Facile synthesis of platelet-activating fetor and racemic analogues containing unsaturation in the sn-1-alkyl chain, J. Med. Chem. 28:73–78.

    Article  Google Scholar 

  • Swendsen, C. L., Ellis, J. M., Chilton, F. H., III, O’Flaherty, J. T., and Wykle, R. L., 1983, 1–0-alkyl-2-acyl-sn-glycero-3-phosphocholine: A novel source of arachidonic acid in neutrophils stimulated by the calcium ionophore A23187, Biochem. Biophys. Res. Commun. 113:72–79.

    Article  PubMed  CAS  Google Scholar 

  • Terashita, Z., Tsushima, S., Yoshioka, Y., Nomura, H., Inada, Y., and Nishikawa, K., 1983, CV-3988—A specific antagonist of platelet activating factor (PAF), Life Sci. 32:1975–1982.

    Article  PubMed  CAS  Google Scholar 

  • Tokumura, A., Homma, H., and Hanahan, D. J., 1985, Structural analogs of alkylacetylglycerophos-phocholine inhibitory behavior on platelet activation, J. Biol. Chem. 260:12710–12714.

    PubMed  CAS  Google Scholar 

  • Valone, F. H., 1984, Isolation of a platelet membrane protein which binds the platelet-activating factor l-0-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine, Immunology 52:169–174.

    PubMed  CAS  Google Scholar 

  • Valone, F. H., 1985a, Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolioethyl phosphate (CV-3988), Biochem. Biophys. Res. Comm. 126:502–508.

    Article  PubMed  CAS  Google Scholar 

  • Valone, F. H., 1985b, Inhibition of PAF binding by the calcium channel blockers diltiazem (Dil) and verapamil (Ver), October 15–18, New Horizons in Platelet Activating Factor Research, Mariner’s Inn, Palmetto Dunes Resort, Hilton Head Island, South Carolina.

    Google Scholar 

  • Valone, F. H., and Goetzl, E. J., 1983, Specific binding by human polymorphonuclear leucocytes of the immunological mediator l-0-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. Immunology 48:141–148.

    PubMed  CAS  Google Scholar 

  • Valone, F. H., Coles, E., Reinhold, V. R., and Goetzl, E. J., 1982, Specific binding of phospholipid platelet-activating factor by human platelets, J. Immunol. 129:1637–1641.

    PubMed  CAS  Google Scholar 

  • Voelkel, N. F., Worthen, S., Reeves, J. T., Henson, P. M., and Murphy, R. C, 1982, Nonim-munological production of leukotrienes induced by platelet-activating factor, Science 218:286–288.

    Article  PubMed  CAS  Google Scholar 

  • White, G. C, II, 1984, Effect of l-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine on calcium fluxes by human platelet microsomes, Biochem. Biophys. Res. Commun. 120:474–480.

    Article  PubMed  CAS  Google Scholar 

  • Williams, K. A., and Haslam, R. J., 1984, Effects of NaCl and GTP on the inhibition of platelet adenylate cyclase by l-0-octadecyl-2–0-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic platelet-activating factor), Biochim. Biophys. Acta. 770:216–223.

    Article  PubMed  CAS  Google Scholar 

  • Wissner, A., Sum, P. E., Schaub, R. E.. Kohler, C. A., and Goldstein, B. M., 1984, Analogues of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain, J. Med. Chem. 27:1174–1181.

    Article  PubMed  CAS  Google Scholar 

  • Wykle, R. L., Miller, C. H., Lewis, J. C., Schmitt, J. D., Smith, J. A., Surles, J. R., Piantadosi, C., and O’Flaherty, J. T., 1981, Stereospecific activity of l-0-alkyl-2–0-acetyl-sn-glycero-3-phos-phocholine and comparison of analogs in the degranulation of platelets and neutrophils, Biochem. Biophys. Res. Commun. 100:1651–1658.

    Article  PubMed  CAS  Google Scholar 

  • Wykle, R. L., Surles, J. R., Piantadosi, C., Salzer, W. L., and O’Flaherty, J. T., 1982, Platelet activating factor (l-0-alkyl-2–0-acetyl-sn-glycero-3-phosphocholine). Activity of analogs lacking oxygen at the 2-position, FEBS Lett. 141:29–32.

    Article  PubMed  CAS  Google Scholar 

  • Yasaka, T., Boxer, L., and Baehner, R. L., 1982, Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF), J. Immunol. 128:1939–1944.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Press, New York

About this chapter

Cite this chapter

O’Flaherty, J.T. (1987). Platelet-Activating Factor: Mechanisms of Cellular Activation. In: Snyder, F. (eds) Platelet-Activating Factor and Related Lipid Mediators. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5284-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5284-6_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5286-0

  • Online ISBN: 978-1-4684-5284-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics